Xylem Common Stock vs Total Stockholder Equity Analysis
XYL Stock | USD 141.02 1.62 1.16% |
Xylem financial indicator trend analysis is more than just analyzing Xylem Inc current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xylem Inc is a good investment. Please check the relationship between Xylem Common Stock and its Total Stockholder Equity accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
Common Stock vs Total Stockholder Equity
Common Stock vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xylem Inc Common Stock account and Total Stockholder Equity. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Xylem's Common Stock and Total Stockholder Equity is -0.18. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Xylem Inc, assuming nothing else is changed. The correlation between historical values of Xylem's Common Stock and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Xylem Inc are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Common Stock i.e., Xylem's Common Stock and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.18 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Common Stock
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from Xylem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xylem Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. The value of Selling General Administrative is expected to slide to about 1.2 B. The value of Tax Provision is estimated to slide to about 79.7 M
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.0B | 2.1B | 2.7B | 1.9B | Total Revenue | 5.2B | 5.5B | 7.4B | 4.9B |
Xylem fundamental ratios Correlations
Click cells to compare fundamentals
Xylem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xylem fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 181.2M | 181.1M | 181.5M | 181.0M | 218.2M | 203.7M | |
Total Assets | 7.7B | 8.8B | 8.3B | 8.0B | 16.1B | 16.9B | |
Other Current Liab | 628M | 787M | 683M | 798M | 945M | 992.3M | |
Total Current Liabilities | 1.5B | 2.0B | 1.4B | 1.6B | 2.2B | 1.3B | |
Total Stockholder Equity | 3.0B | 3.0B | 3.2B | 3.5B | 10.2B | 10.7B | |
Other Liab | 1.0B | 1.3B | 1.2B | 730M | 839.5M | 787.3M | |
Property Plant And Equipment Net | 658M | 657M | 644M | 630M | 1.5B | 1.6B | |
Net Debt | 1.6B | 1.2B | 1.1B | 1.0B | 1.6B | 1.2B | |
Accounts Payable | 597M | 569M | 639M | 723M | 968M | 536.4M | |
Cash | 724M | 1.9B | 1.3B | 944M | 1.0B | 721.5M | |
Non Current Assets Total | 5.3B | 5.2B | 5.1B | 4.9B | 12.2B | 12.8B | |
Non Currrent Assets Other | 589M | 623M | 664M | 360M | 415M | 325.2M | |
Other Assets | 348M | 623M | 664M | 661M | 760.2M | 798.2M | |
Cash And Short Term Investments | 724M | 1.9B | 1.3B | 944M | 1.0B | 721.5M | |
Net Receivables | 1.0B | 923M | 953M | 1.1B | 1.6B | 998.3M | |
Good Will | 2.8B | 2.9B | 2.8B | 2.7B | 7.6B | 8.0B | |
Liabilities And Stockholders Equity | 7.7B | 8.8B | 8.3B | 8.0B | 16.1B | 16.9B | |
Non Current Liabilities Total | 3.2B | 3.8B | 3.7B | 2.9B | 3.7B | 2.7B | |
Inventory | 539M | 558M | 700M | 799M | 1.0B | 601.9M | |
Other Current Assets | 151M | 167M | 158M | 173M | 230M | 159.6M | |
Total Liab | 4.7B | 5.8B | 5.1B | 4.4B | 5.9B | 4.0B | |
Property Plant And Equipment Gross | 658M | 657M | 1.8B | 1.8B | 2.5B | 2.6B | |
Total Current Assets | 2.5B | 3.5B | 3.2B | 3.0B | 3.9B | 2.5B | |
Accumulated Other Comprehensive Income | (375M) | (413M) | (371M) | (226M) | (269M) | (255.6M) | |
Intangible Assets | 1.2B | 1.1B | 1.0B | 930M | 2.5B | 2.7B | |
Property Plant Equipment | 658M | 657M | 644M | 630M | 724.5M | 599.5M | |
Short Long Term Debt Total | 2.3B | 3.1B | 2.4B | 1.9B | 2.7B | 2.2B | |
Net Tangible Assets | (1.1B) | (979M) | (590M) | (155M) | (139.5M) | (146.5M) | |
Noncontrolling Interest In Consolidated Entity | 14M | 10M | 8M | 9M | 10.4M | 7.5M | |
Retained Earnings | 1.9B | 1.9B | 2.2B | 2.3B | 2.6B | 1.4B | |
Long Term Debt | 2.0B | 2.5B | 2.4B | 1.9B | 2.3B | 2.0B | |
Retained Earnings Total Equity | 1.9B | 1.9B | 2.2B | 2.3B | 2.6B | 1.3B | |
Long Term Debt Total | 2.0B | 2.5B | 2.4B | 1.9B | 2.2B | 1.9B | |
Capital Surpluse | 2.0B | 2.0B | 2.1B | 2.1B | 2.5B | 2.1B | |
Other Stockholder Equity | 1.5B | 1.4B | 1.4B | 1.4B | 7.8B | 8.2B | |
Deferred Long Term Liab | 310M | 242M | 287M | 222M | 255.3M | 254.2M | |
Treasury Stock | (527M) | (588M) | (656M) | (708M) | (637.2M) | (605.3M) |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Xylem Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Xylem Stock analysis
When running Xylem's price analysis, check to measure Xylem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xylem is operating at the current time. Most of Xylem's value examination focuses on studying past and present price action to predict the probability of Xylem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xylem's price. Additionally, you may evaluate how the addition of Xylem to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Xylem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.167 | Dividend Share 1.35 | Earnings Share 2.88 | Revenue Per Share 34.207 | Quarterly Revenue Growth 0.404 |
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.